Mitochondrial heterogeneity, metabolic scaling and cell death
Researchers study it in the context of nicotinamide N methyltransferase activity, methylation related pathways, and cellular metabolism
Treatment of myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) with hexamethylene bisacetamide (HMBA)
I believe that everybody will have this sometime in the future, I dont know when, but do you want to explain to people listening, because not everyones going to know the concept behind the polygenic risk, so I might as well let
(Peptide Sciences) Use in post-treatment settings: e.g., after chemo/radiation when senescent cells accumulate and impair recovery, or in surgical recovery settings
Synthesis and characterization of the N-terminal acetylated 17-23 fragment of thymosin beta 4 identified in TB-500